elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26992262-0C3BB93F-A4B3-4A09-9154-A02A8B845000
Q26992262-0C3BB93F-A4B3-4A09-9154-A02A8B845000
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26992262-0C3BB93F-A4B3-4A09-9154-A02A8B845000
Measuring anti-factor xa activity to monitor low-molecular-weight heparin in obesity: a critical review
P2860
Q26992262-0C3BB93F-A4B3-4A09-9154-A02A8B845000
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26992262-0C3BB93F-A4B3-4A09-9154-A02A8B845000
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d491627f3be3d0769be8db2b1efe3524ae49b62c
P2860
A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery.